Stockreport

Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Immuneering Corporation - Class A  (IMRX) 
PDF NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and [Read more]